Exalgo FDA Approval History
Marketing Status: Discontinued
Exalgo (hydromorphone) is a once-a-day extended release opioid formulation for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
Development Timeline for Exalgo
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.